On Aug 06, 2026, DOCS reported earnings of 0.28 USD per share (EPS) for Q1 27, missing the estimate of 0.31 USD, resulting in a -6.66% surprise. Revenue reached 156.62 million, compared to an expected 154.76 million, with a 1.20% difference. The market reacted with a +32.62% price change (close before vs. close after earnings).
Looking ahead to Q2 27, 15 analysts forecast an EPS of 0.35 USD, with revenue projected to reach 173.93 million USD, implying an increase of 25.00% EPS, and increase of 11.05% in Revenue from the last quarter.